We estimate that the CEO of Rapport Therapeutics, Inc. ($RAPP), Abraham Ceesay, M.B.A., received a compensation of $6,265,174 in 2025. This is a decrease of -57.05% from an estimated $9,839,157 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 23, 2026. Note that parsing errors may occur.
You can track $RAPP on Quiver Quantitative's $RAPP stock dashboard.
$RAPP Stock Insider Trading Activity
$RAPP Stock insiders have traded $RAPP stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.
Here’s a breakdown of recent trading of $RAPP stock by insiders over the last 6 months:
- ROCK VENTURES V, L.P. THIRD sold 426,005 shares for an estimated $17,175,243
- KRISHNASWAMY YELESWARAM (Chief Development Officer) has made 0 purchases and 6 sales selling 50,565 shares for an estimated $1,820,586.
- ABRAHAM CEESAY (Chief Executive Officer) has made 0 purchases and 16 sales selling 43,664 shares for an estimated $1,203,999.
- DAVID BREDT (Chief Scientific Officer) has made 0 purchases and 9 sales selling 34,000 shares for an estimated $944,007.
- CHERYL GAULT (Chief Operating Officer) has made 0 purchases and 4 sales selling 17,014 shares for an estimated $490,608.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RAPP Stock Hedge Fund Activity
We have seen 84 institutional investors add shares of $RAPP Stock stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,616,661 shares (-73.3%) from their portfolio in Q4 2025, for an estimated $79,389,494
- BLACKROCK, INC. added 863,781 shares (+55.1%) to their portfolio in Q4 2025, for an estimated $26,207,115
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 472,739 shares (-66.8%) from their portfolio in Q4 2025, for an estimated $14,342,901
- SIREN, L.L.C. removed 345,000 shares (-32.7%) from their portfolio in Q4 2025, for an estimated $10,467,300
- STATE STREET CORP added 343,195 shares (+92.3%) to their portfolio in Q4 2025, for an estimated $10,412,536
- UBS GROUP AG removed 331,713 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $10,064,172
- PERCEPTIVE ADVISORS LLC added 270,000 shares (+66.8%) to their portfolio in Q4 2025, for an estimated $8,191,800
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RAPP Stock Analyst Ratings
Wall Street analysts have issued reports on $RAPP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 02/02/2026
- HC Wainwright & Co. issued a "Buy" rating on 12/09/2025
- BTIG issued a "Buy" rating on 12/08/2025
- Citizens issued a "Market Outperform" rating on 11/07/2025
To track analyst ratings and price targets for $RAPP Stock, check out Quiver Quantitative's $RAPP forecast page.
$RAPP Stock Price Targets
Multiple analysts have issued price targets for $RAPP recently. We have seen 4 analysts offer price targets for $RAPP in the last 6 months, with a median target of $49.5.
Here are some recent targets:
- Kambiz Yazdi from BTIG set a target price of $53.0 on 04/22/2026
- Benjamin Burnett from Wells Fargo set a target price of $46.0 on 03/11/2026
- Douglas Tsao from HC Wainwright & Co. set a target price of $40.0 on 12/09/2025
- Jason N. Butler from Citizens set a target price of $80.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
